These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 10874853)

  • 1. [New perspectives in the treatment of hypertension: the contribution of rilmenidine].
    Polónia J
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II21-6. PubMed ID: 10874853
    [No Abstract]   [Full Text] [Related]  

  • 2. Imidazoline Receptors: A Novel Approach to Hypertension--the Contribution of Rilmenidine. Symposium proceedings. Milan, Italy, June 8, 1993.
    Am J Cardiol; 1994 Dec; 74(13):1A-65A. PubMed ID: 7998579
    [No Abstract]   [Full Text] [Related]  

  • 3. Second International Symposium on Rilmenidine. Paris, March 11, 1988. Proceedings.
    Am J Med; 1989 Sep; 87(3C):1S-74S. PubMed ID: 2782322
    [No Abstract]   [Full Text] [Related]  

  • 4. Rilmenidine and the high risk hypertensive patient.
    Laragh JH
    Ann N Y Acad Sci; 1995 Jul; 763():634-41. PubMed ID: 7677383
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of rilmenidine versus captopril on microalbuminuria: a pilot study in hypertensive type 2 diabetics.
    Bauduceau B; Mayaudon H; Dupuy O
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):547-8. PubMed ID: 10686665
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical benefits of rilmenidine.
    Kourilsky O
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II27-32. PubMed ID: 10874854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Scemama M; Février B; Beucler I; Dairou F
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
    Panfilov V; Morris AD; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New, modern, centrally active antihypertensive agents in the treatment of essential hypertension].
    Sevcík J; Masek K
    Cas Lek Cesk; 1999 Jun; 138(12):359-62. PubMed ID: 10566202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of rilmenidine on rats made insulin resistant and hypertensive by a high fructose diet].
    Berthault MF; Morin J; Dubar M; Ktorza A; Ferré P; Pénicaud L
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1103-6. PubMed ID: 8949387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imidazoline receptors and use of drug blocking receptors I1].
    Lada W
    Pol Merkur Lekarski; 1996 Aug; 1(2):124-5. PubMed ID: 9156911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():53-7. PubMed ID: 2534268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rilmenidine in patients with left ventricular hypertrophy: beyond the reduction of left ventricular mass.
    Trimarco B; Morisco C; Sarno D; Iovino G; Argenziano L; Russo R; De Luca N; Volpe M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S29-33. PubMed ID: 8642802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imidazol receptor agonists--new possibilities for treating hypertension].
    Nowicki M; Wiecek A; Chudek J
    Postepy Hig Med Dosw; 1995; 49(5):631-43. PubMed ID: 8677226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazoline Receptors in a Comprehensive Approach to Hypertension. Proceedings of an international symposium. Berlin, Germany, September 10, 1994.
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S1-67. PubMed ID: 8642799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Imidazole receptor agonists--a new advance in the treatment of hypertension?].
    Spinar J; Vítovec J
    Vnitr Lek; 2000 Feb; 46(2):122-5. PubMed ID: 11048538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
    Scemama M; Février B; Beucler I; Dairou F
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation.
    Licata G; Scaglione R; Guillet C; Capuana G; Parrinello G; Indovina A; Lipari R; Mazzola G; Merlino G
    J Hum Hypertens; 1993 Apr; 7(2):153-7. PubMed ID: 8510088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.